Pld1 inhibitors reportedly promote Treg differentiation in vitro to improve the validation response in autoimmune diseases (51); the effect of Spin1 on the proliferation and migration of tumor cells has been demonstrated in most tumor studies whereas studies on immune function have been rarely reported. This evidence concerns the gene PLD1 and autoimmune disease.